Update in pulmonary hypertension 2005

被引：32

作者：

Hoeper, MM ^{[1
]}

Rubin, LJ

机构：

[1] Hannover Med Sch, Dept Resp Med, D-30623 Hannover, Germany

[2] Univ Calif San Diego, Pulm Vasc Program, La Jolla, CA 92093 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2006年 / 173卷 / 05期

关键词：

D O I：

10.1164/rccm.2512003

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：499 / 505

页数：7

共 92 条

[21] Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension - A randomized prospective study [J].

Ghofrani, HA ;

Voswinckel, R ;

Reichenberger, F ;

Olschewski, H ;

Haredza, P ;

Karadas, B ;

Schermuly, RT ;

Weissmann, N ;

Seeger, W ;

Grimminger, F .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (07) :1488-1496

[22] Imatinib for the treatment of pulmonary arterial hypertension [J].

Ghofrani, HA ;

Seeger, W ;

Grimminger, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1412-1413

[23] REDUCED EXPRESSION OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE IN THE LUNGS OF PATIENTS WITH PULMONARY-HYPERTENSION [J].

GIAID, A ;

SALEH, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (04) :214-221

[24] Decreased exhaled nitric oxide in pulmonary arterial hypertension - Response to bosentan therapy [J].

Girgis, RE ;

Champion, HC ;

Diette, GB ;

Johns, RA ;

Permutt, S ;

Sylvester, JT .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (03) :352-357

[25] Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension [J].

Gomberg-Maitland, M ;

Tapson, VF ;

Benza, RL ;

McLaughlin, VV ;

Krichman, A ;

Widlitz, AC ;

Barst, RJ .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (12) :1586-1589

[26] Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats [J].

Guignabert, C ;

Raffestin, B ;

Benferhat, R ;

Raoul, W ;

Zadigue, P ;

Rideau, D ;

Hamon, M ;

Adnot, S ;

Eddahibi, S .

CIRCULATION, 2005, 111 (21) :2812-2819

[27] Transforming growth factor-β receptor mutations and pulmonary arterial hypertension in childhood [J].

Harrison, RE ;

Berger, R ;

Haworth, SG ;

Tulloh, R ;

Mache, CJ ;

Morrell, NW ;

Aldred, MA ;

Trembath, RC .

CIRCULATION, 2005, 111 (04) :435-441

[28] Absence of Kaposi's sarcoma-associated herpesvirus in patients with pulmonary arterial hypertension [J].

Henke-Gendo, C ;

Mengel, M ;

Hoeper, MM ;

Alkharsah, K ;

Schulz, TF .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (12) :1581-1585

[29] Soluble guanylate cyclase: an old therapeutic target re-visited [J].

Hobbs, AJ .

BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (05) :637-639

[30] Bosentan therapy for portopulmonary hypertension [J].

Hoeper, MM ;

Halank, M ;

Marx, C ;

Hoeffken, G ;

Seyfarth, HJ ;

Schauer, J ;

Niedermeyer, J ;

Winkler, J .

EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (03) :502-508

← 1 2 3 4 5 6 7 8 9 10 →